Waypoint Capital Advisors’s Apogee Therapeutics APGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
$36.8M Buy
+627,089
New +$36.8M 7.84% 2